Knowledge Action Portal on NCDs

Scoping Review of Economic Analyses of Rare Kidney Diseases

International Society of Nephrology

10 Dec 2024

Scoping Review of Economic Analyses of Rare Kidney Diseases

Rare kidney diseases (RKDs) place a substantial economic burden on patients and health systems, the extent of which is unknown and may be systematically underestimated by health economic techniques. We aimed to investigate the economic burden and cost-effectiveness evidence base for RKDs.

Access
Article

Related Resources

The Lancet

Strengthening non-communicable disease care in all-hazards emergencies

Article

16 Sep 2025

The Lancet

Metrics for diplomats: is mortality from non-communicable diseases increasing or decreasing?

Article

03 Jul 2025

The International League of Dermatological Societies

ILDS Response to the Zero Draft of the Political Declaration of the Fourth High-level Meeting of the General Assembly on the Prevention and Control of Noncommunicable Diseases and the Promotion of Mental Health and Well-being

Article

25 Jun 2025

NCD Alliance

NCDA Analysis of the 78th session of the World Health Assembly (WHA78)

Article

24 Jun 2025

Nature Reviews Nephrology

Kidney disease is a worldwide killer. Treat it that way

Article

24 Apr 2025

Palliative Medicine Reports

Palliative Care in Public Policy: Results from a Global Survey

Article

16 Apr 2025
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Read More